These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 7690218)
1. Transformation-associated Epstein-Barr virus antigens as targets for immune attack. Masucci MG; Gavioli R; de Campos-Lima PO; Zhang QJ; Trivedi P; Dolcetti R Ann N Y Acad Sci; 1993 Aug; 690():86-100. PubMed ID: 7690218 [No Abstract] [Full Text] [Related]
2. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. Levitsky V; Zhang QJ; Levitskaya J; Masucci MG J Exp Med; 1996 Mar; 183(3):915-26. PubMed ID: 8642295 [TBL] [Abstract][Full Text] [Related]
3. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641 [TBL] [Abstract][Full Text] [Related]
4. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [TBL] [Abstract][Full Text] [Related]
5. An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformants. Burrows SR; Misko IS; Sculley TB; Schmidt C; Moss DJ J Virol; 1990 Aug; 64(8):3974-6. PubMed ID: 1695259 [TBL] [Abstract][Full Text] [Related]
7. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. Hill AB; Lee SP; Haurum JS; Murray N; Yao QY; Rowe M; Signoret N; Rickinson AB; McMichael AJ J Exp Med; 1995 Jun; 181(6):2221-8. PubMed ID: 7539044 [TBL] [Abstract][Full Text] [Related]
8. Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3. Burrows SR; Gardner J; Khanna R; Steward T; Moss DJ; Rodda S; Suhrbier A J Gen Virol; 1994 Sep; 75 ( Pt 9)():2489-93. PubMed ID: 7521394 [TBL] [Abstract][Full Text] [Related]
9. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. Khanna R; Burrows SR; Kurilla MG; Jacob CA; Misko IS; Sculley TB; Kieff E; Moss DJ J Exp Med; 1992 Jul; 176(1):169-76. PubMed ID: 1377222 [TBL] [Abstract][Full Text] [Related]
10. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases. Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683 [TBL] [Abstract][Full Text] [Related]
11. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2. Khanna R; Burrows SR; Suhrbier A; Jacob CA; Griffin H; Misko IS; Sculley TB; Rowe M; Rickinson AB; Moss DJ J Immunol; 1993 Jun; 150(11):5154-62. PubMed ID: 7684421 [TBL] [Abstract][Full Text] [Related]
12. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3). Burrows SR; Sculley TB; Misko IS; Schmidt C; Moss DJ J Exp Med; 1990 Jan; 171(1):345-9. PubMed ID: 1688611 [TBL] [Abstract][Full Text] [Related]
13. [Role of the Epstein-Barr virus in human pathology]. Rupniewska ZM Acta Haematol Pol; 1979; 10(3):183-91. PubMed ID: 228518 [No Abstract] [Full Text] [Related]
14. Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro. Sugden B Rev Infect Dis; 1982; 4(5):1048-61. PubMed ID: 6293034 [TBL] [Abstract][Full Text] [Related]
15. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681 [TBL] [Abstract][Full Text] [Related]
16. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus and human malignancy. Ziegler JL; Magrath IT; Gerber P; Levine PH Ann Intern Med; 1977 Mar; 86(3):323-36. PubMed ID: 190930 [TBL] [Abstract][Full Text] [Related]